🧪
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
jamanetwork.com
This study evaluates the quantile-aggregation method using both simulated data and publicly available Alzheimer disease randomized trial data.